Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion

Enrolling by invitation

Conditions studied: Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis

In brief

The aim of this study is to evaluate the effectiveness and safety of Natural Matrix Protein™ (NMP™) fibers when used in cervical or lumbar interbody fusion in patients with degenerative disc disease (DDD), spinal stenosis, spondylolisthesis undergoing cervical or lumbar interbody spine fusion at no more than 3 adjacent levels.

Key facts

Study ID
NCT06000319
Run by
Induce Biologics USA Inc.
People needed
200
Starts
2024-01-04
Expected to finish
2027-08-01
Last updated by the study team
2025-11-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.